Virtual Science AI Launches Competitor Tracking Platform for Pharma
Virtual Science AI announced in a press release the launch of Medical Competitor AI, a new platform that applies artificial intelligence to track competitor medical activities and scientific narratives. The system is designed to support pharmaceutical companies in planning and executing asset launches.
The platform provides intelligence on competitor activities such as conference presentations, publications, and social engagement. It also analyzes how the scientific community responds to these activities, helping teams refine their own medical narratives and focus resources effectively.
Medical Competitor AI expands the company’s existing medical intelligence suite, which includes tools for integrated medical intelligence, social intelligence, and congress insights. The new product is already in use by several major pharmaceutical firms and is part of a planned series of releases addressing key intelligence needs in life sciences.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Veeva to Showcase Falcon and Vault AI at Boston Summit
MediSights Reports Study Using AI Agents for Myeloma Market Research
GenScript and NVIDIA Open Life Sciences AI Startup PitchFest
Trustpilot Adds Product Review Pages and AI Search Tools
SPINS Launches Agentic Discovery for AI Product Visibility
Daily AI Brief: the AI news that matters, in your inbox.